Insider Transactions Reported by 21 Insiders of Cidara Therapeutics, Inc.

Location
San Diego, CA

Insiders trading volume in the past year

Cidara Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
RA CAPITAL MANAGEMENT, L.P. Director, 10%+ Owner $19,188,424 +$99,999,988 07 Jan 2026
Leslie Tari Chief Scientific Officer $357,727 11 Mar 2025
Taylor Sandison Chief Medical Officer $268,424 30 Sep 2024
Preetam Shah Chief Financial Officer $231,812 30 Sep 2024
Paul Daruwala Chief Operating Officer $209,602 12 Sep 2022
Brady Johnson Vice President, Finance $56,279 31 Mar 2022
Jeffrey Stein President & CEO, Director $0 07 Jan 2026
Shane Ward Coo & Clo $0 -$2,191,747 -100% 07 Jan 2026
FRANK KARBE Chief Financial Officer $0 07 Jan 2026
DANIEL D. BURGESS Director $0 07 Jan 2026
Chrysa Mineo Director $0 +$73,896 07 Jan 2026
Nicole Negar Davarpanah Chief Medical Officer $0 -$29,797 -100% 07 Jan 2026
Bonnie L. Bassler Director $0 07 Jan 2026
James Merson Director 07 Jan 2026
Joshua Resnick Director 07 Jan 2026
Carin Canale-Theakston Director 07 Jan 2026
David L. Gollaher Director 22 Jun 2023
Timothy R. Franson Director 22 Jun 2023
Ryan Spencer Director 07 Jan 2026
Laura Tadvalkar Director 18 Jul 2024
Theodore R. Schroeder Director 07 Jan 2026

Recent Insider Transactions by Companies or Individuals for Cidara Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.